Research designs to generate evidence of HIV post‐exposure prophylaxis effectiveness for new long‐acting agents

Research designs to generate evidence of HIV post‐exposure prophylaxis effectiveness for new long‐acting agents

Abstract Introduction New longer‐acting antiretroviral (ARV) drugs—that is single doses with antiviral activity for at least a month—are being utilized for HIV treatment and pre‐exposure prophylaxis (PrEP) but have not been explored for post‐exposure prophylaxis (PEP). A “one‐and‐done” simplificatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Katrina F. Ortblad, Elizabeth R. Brown, Renee Heffron, Kenneth Ngure, Andrew Mujugira, Deborah Donnell
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Journal of the International AIDS Society
Subjects:
effectiveness
HIV
HIV prevention
long‐acting prophylaxis
post‐exposure prophylaxis
study designs
Online Access:https://doi.org/10.1002/jia2.26475
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jia2.26475

Similar Items